Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunomorphology and molecular biology of mixed primary liver cancers: is Nestin a marker of intermediate‐cell carcinoma?

2 Aug 2019

Abstract excerpt

AIMS: Primary mixed liver cancers (PLCs), combined hepatocellular-cholangiocellular (cHCC-CC) and intermediate-cell carcinomas are rare tumours characterised by different molecular mechanisms. Nestin is a marker of progenitor cells with a promising application in human tumours. The aims of the present paper are (i) to determine the expression of Nestin in mixed PLCs; and (ii) to correlate the PLC immunoprofile...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to Genetic and Kidney Cyst Diseases
Share to Hepatocellular Carcinoma Treatment and Prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31374137
DOI: 10.1111/his.13966

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunomorphology and molecular biology of mixed primary liver cancers: is Nestin a marker of intermediate‐cell carcinoma?PMID 31374137Read ↗

Is nestin a diagnostic marker for combined hepatocellular-cholangiocarcinoma?Semantic proximity Read ↗

Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.Semantic proximity Read ↗

Heterogeneous Intermediate Phenotypes of Cancer Cells with Varying Ki-67-Positivity Rates, Including Histologically HCC-like and NEC-like Cells, in Liver MiNEN.Semantic proximity Read ↗

Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma.Semantic proximity Read ↗

Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristics.Semantic proximity Read ↗

Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.Semantic proximity Read ↗

Composite liver tumors: a radiologic-pathologic correlation.Semantic proximity Read ↗

Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer.Semantic proximity Read ↗

Evidence of Distinct Tumour-Propagating Cell Populations with Different Properties in Primary Human Hepatocellular CarcinomaSemantic proximity Read ↗

Clinicopathological, radiologic, and molecular study of 23 combined hepatocellular-cholangiocarcinomas with stem cell features, cholangiolocellular type.Semantic proximity Read ↗

Nestin expression in human tumors and tumor cell lines.Semantic proximity Read ↗

Clinicopathological Significance of Nestin Expression as a Diagnostic and Prognostic Marker in Brain Gliomas, Independent of IDH MutationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.